New Breakthrough in Ovarian Cancer Research!
A groundbreaking study published in Advanced Science titled ”Splicing Factor PQBP1 Curtails BAX Expression to Promote Ovarian Cancer Progression” unveils a critical mechanism driving cancer development!
Researchers discovered that PQBP1 —a splicing factor typically active in the central nervous system—is overexpressed in ovarian cancer. Using cutting-edge techniques like spyCLIP-seq and RNA-seq, the team found that PQBP1 binds to exon regions, forcing exon skipping in the BAX gene. This results in a truncated, non-functional BAX protein that is quickly degraded, making cancer cells resistant to apoptosis.
Therapeutic Hope! By reducing PQBP1 levels or using splice-switching antisense oligonucleotides (ASOs), scientists successfully restored BAX expression, slowing tumor growth . This highlights PQBP1’s oncogenic role and positions it as a promising therapeutic target!
Nanopore long-read RNA-seq by BMKGENE played a pivotal role in uncovering these insights, showcasing the power of advanced genomics in cancer research!
This discovery not only deepens our understanding of ovarian cancer biology but also opens doors for precision medicine strategies to combat this deadly disease. A win for Women health and cancer research!
If you would like to learn more about this study, access this link. For more information on our sequencing and bioinformatics services, you can talk to us here.
Post time: May-30-2025
